Clinical Trials List
Protocol Number99-2981A
2010-08-01 - 2014-07-31
Phase II
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kun-Ju Lin Division of Nuclear Medicine
- 黃英儒 Division of Neurology
- Tzu-Chen Yen Division of Nuclear Medicine
- 林皇利 Division of Psychiatry
- Rou-Shayn Chen Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
0 participants
